Philips Files 6-K Report
Ticker: RYLPF · Form: 6-K · Filed: May 15, 2024 · CIK: 313216
Sentiment: neutral
Topics: sec-filing, foreign-issuer, administrative
TL;DR
Philips filed a 6-K, confirming 20-F annual reports and Dutch HQ.
AI Summary
Koninklijke Philips NV filed a Form 6-K on May 15, 2024. The filing is a report of a foreign issuer and indicates that Philips files annual reports under Form 20-F. The company's principal executive offices are located in Amsterdam, The Netherlands.
Why It Matters
This filing is a routine disclosure for foreign issuers, providing an update on their reporting status and administrative details to the SEC.
Risk Assessment
Risk Level: low — This is a standard administrative filing for a foreign issuer and does not contain new financial or operational information.
Key Players & Entities
- Koninklijke Philips NV (company) — Registrant
- Royal Philips (company) — Registrant's name in English
- The Netherlands (location) — Jurisdiction of incorporation
- Amsterdam (location) — Principal executive offices city
- May 15, 2024 (date) — Filing date
FAQ
What type of SEC form is Koninklijke Philips NV filing?
Koninklijke Philips NV is filing a Form 6-K, which is a report of a foreign issuer.
Under which form does Koninklijke Philips NV file its annual reports?
Koninklijke Philips NV files its annual reports under Form 20-F.
Where are the principal executive offices of Koninklijke Philips NV located?
The principal executive offices of Koninklijke Philips NV are located in Amsterdam, The Netherlands.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is May 15, 2024.
What is the jurisdiction of incorporation for Koninklijke Philips NV?
The jurisdiction of incorporation for Koninklijke Philips NV is The Netherlands.
Filing Stats: 623 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-05-15 07:20:52
Filing Documents
- phg-20240515.htm (6-K) — 11KB
- visual0001.jpg (GRAPHIC) — 93KB
- visual0002.jpg (GRAPHIC) — 77KB
- 0000313216-24-000010.txt ( ) — 231KB
From the Filing
Philips - 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 May 15, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission: M.J. van Ginneken Koninklijke Philips N.V. Amstelplein 2 1096 BC Amsterdam – The Netherlands This report comprises a copy of the following press release: “ Philips announces exchange ratio for 2023 dividend ", dated May 15, 2024 . Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on May 15, 2024. KONINKLIJKE PHILIPS N.V. /s/ M.J. van Ginneken (Chief Legal Officer) Press information May 15, 2024 Philips announces exchange ratio for 2023 dividend Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,860,582 new common shares. Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 16, 2024. Upon distribution, the total issued share capital will amount to EUR 188,875,310 representing 944,376,548 common shares. In the second quarter, Philips intends to cancel 4,437,164 shares that were acquired under the now completed EUR 1.5 billion share repurchase program for capital reduction purposes, as announced on July 26, 2021. Post cancellation, the total number of issued shares will amount to 939,939,384 common shares. More information is available via this link. For further information, please contact: Ben Zwirs Philips External Relations Tel.: +31 6 1521 3446 E-mail: Ben.Zwirs@philips.com Dorin Danu Philips Investor Relations Tel.: +31 20 59 77055 E-mail: dorin.danu@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.